Edition:
United States

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

44.49USD
21 Sep 2018
Change (% chg)

-- (--)
Prev Close
$44.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
345,106
52-wk High
$73.90
52-wk Low
$16.17

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 1.09 -0.819
Mar '18 1.36 -0.617
FY 2017 Dec '17 32.33 0.159
Sep '17 2.39 -0.616
Jun '17 3.58 -0.559
Mar '17 2.70 -0.541
FY 2016 Dec '16 2.34 1.395
Sep '16 1.55 -0.369
Jun '16 0.80 -0.432
Mar '16 0.48 -0.212
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 3.00 9.50 0.50 6.40
Quarter Ending Dec-18 5 3.96 11.30 0.50 7.80
Year Ending Dec-18 6 8.79 24.00 3.40 13.93
Year Ending Dec-19 7 19.74 91.10 0.00 31.10
Earnings (per share)
Quarter Ending Sep-18 7 -0.73 -0.51 -0.85 -0.67
Quarter Ending Dec-18 7 -0.78 -0.61 -0.92 -1.06
Year Ending Dec-18 7 -2.90 -2.38 -3.21 -3.02
Year Ending Dec-19 8 -3.19 -1.87 -4.31 -3.06
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.33 32.69
P/E High - Last 5 Yrs. -- 278.75 47.23
P/E Low - Last 5 Yrs. -- 97.93 24.79
Beta -- 0.61 0.87
Price to Sales (TTM) 56.50 110.30 6.46
Price to Book (MRQ) 7.90 12.48 3.90
Price to Tangible Book (MRQ) 7.93 18.90 5.96
Price to Cash Flow (TTM) -- 62.41 23.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -69.63 175.09 8.38
Sales (TTM) vs TTM 1 Yr. Ago 265.08 92.96 6.69
Sales - 5 Yr. Growth Rate -- 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -46.49 283.36 25.56
EPS (TTM) vs TTM 1 Yr. Ago -2,449.86 -- --
EPS - 5 Yr. Growth Rate -- 23.65 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.57 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.19
Current Ratio (MRQ) 17.89 5.49 2.97
LT Debt to Equity (MRQ) 0.00 15.10 11.24
Total Debt to Equity (MRQ) 0.00 18.62 14.06
Interest Coverage (TTM) -2.23 -215.83 35.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.67
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -224.85 -- --
EBITD - 5 Yr. Avg -- -177.00 15.88
Operating Margin (TTM) -233.82 -607.80 3.65
Operating Margin - 5 Yr. Avg. -- -190.63 11.00
Pre-Tax Margin (TTM) -242.04 -604.88 3.97
Pre-Tax Margin - 5 Yr. Avg. -- -193.42 11.19
Net Profit Margin (TTM) -228.61 -599.69 0.70
Net Profit Margin - 5 Yr. Avg. -- -191.17 7.52
Effective Tax Rate (TTM) -- 11.60 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.16 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 292,583 5,335,375 714,979,821
Net Income/Employee (TTM) -668,866 -5,831,664 82,568,832
Receivable Turnover (TTM) 9.58 4.20 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) 0.11 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -25.82 0.80 9.75
Return on Assets - 5 Yr. Avg. -- 2.53 10.91
Return on Investment (TTM) -27.23 1.50 12.72
Return on Investment - 5 Yr. Avg. -- 2.04 14.03
Return on Equity (TTM) -36.70 0.19 14.85
Return on Equity - 5 Yr. Avg. -- -2.23 15.38
  1 Year 3 Year 5 Year
Sales % 693.90 -- --
EPS (TTM) % 18.07 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CRISPR Therapeutics AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.12 -9.84 61 74
13 Week -29.13 -33.36 33 56
26 Week -15.99 -25.78 80 45
52 Week 133.91 99.65 99 88
YTD 89.48 72.92 99 80
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.65%
# of Holders: 217
Total Shares Held: 19,185,205
3 Mo. Net Change: -350,487
# New Positions: 82
# Closed Positions: 29
# Increased Positions: 144
# Reduced Positions: 66
# Net Buyers: 78
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.